P. Kent Hawryluk

MBX

P. Kent Hawryluk serves as director, officer: President & CEO at MBX Biosciences, Inc. Common Stock (MBX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$1.33M

Total Sells

1 trades

$17.9K

Net Position

Net Buyer

$1.32M

Companies Traded

MBX

Active Period

Feb 2025 – May 2026

4 total trades

Most Recent

Sell MBX

May 8, 2026 · $17.9K

P. Kent Hawryluk's Insider Trading at MBX Biosciences, Inc. Common Stock (MBX)

Buys

3 · $1.33M

Sells

1 · $17.9K

Total Shares Bought

88,500

Total Shares Sold

607

MBX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 8, 2026	Sell	607	$29.54	$17.9K	727,667
Mar 16, 2026	Buy	18,500	$28.41	$525.7K	486,777
Oct 20, 2025	Buy	20,000	$13.64	$272.8K	0
Feb 5, 2025	Buy	50,000	$10.69	$534.5K	448,277

Related Insiders

Salomon Azoulay

officer: Chief Medical Officer

MBXSell · May 11, 2026

Steven L. Hoerter

Director

MBXBuy · Oct 17, 2025

Patrick J Heron

Director

MBXBuy · Sep 26, 2025

Explore More Insider Trading Data

MBX Insider Trading Activity

View all insider trades at MBX Biosciences, Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity